Publications by authors named "YuMin Wen"

Claim this Profile
C
Cardiovascular Protective Effects of Oral Hypoxia Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat in the Treatment of Type 4 Cardiorenal-Anemia Syndrome: Protocol of a Randomized Controlled Trial.
Yumin Wen, Yang Xu, Hui Tian, Sizhu Jiang, Guofang Jiang

Front Med (Lausanne)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease.
Xue-Feng Zhou, Wei-E Zhou, Wen-Jing Liu, Min-Jing Luo, Xia-Qing Wu, Yu-Min Wen

J Transl Int Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Epoxide Hydrolase 2 Gene Arg287Gln with the Risk for Primary Hypertension in Chinese.
Liang Ma, Hailing Zhao, Meijie Yu, Yumin Wen, Tingting Zhao, Wenquan Niu

Int J Hypertens· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese medicine for diabetic kidney disease in China.
Yumin Wen, Meihua Yan, Bingxuan Zhang, Ping Li

Nephrology (Carlton)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
TingTing Zhao, SiFan Sun, HaoJun Zhang, XiaoRu Huang, MeiHua Yan, YuMin Wen

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
Xin Yang, Bingxuan Zhang, Xiaoguang Lu, Meihua Yan, Yumin Wen

BMC Complement Altern Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.
Meihua Yan, Yumin Wen, Liping Yang, Xi'ai Wu, Xiaoguang Lu

Trials· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.
Ping Li, Yiping Chen, Jianping Liu, Jing Hong, Yueyi Deng, Yumin Wen, Wenying Yang

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yi Qi Qing Re Gao-containing serum inhibits lipopolysaccharide-induced rat mesangial cell proliferation by suppressing the Wnt pathway and TGF-β1 expression.
Liping Yang, Xueyan Sun, Yongli Zhan, Huijie Liu, Yumin Wen

Exp Ther Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onychomycosis Associated with Exophiala oligosperma in Taiwan.
Yu-Min Wen, Ranjith Kumar Rajendran, Ying-Fang Lin, Roland Kirschner, Sindy Hu

Mycopathologia· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renoprotective effect of berberine on type 2 diabetic nephropathy in rats.
Si-Fan Sun, Ting-Ting Zhao, Hao-Jun Zhang, Xiao-Ru Huang, Wei-Ku Zhang, Yu-Min Wen

Clin Exp Pharmacol Physiol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside-induced nephrosis by suppressing inflammation and apoptosis.
Yumin Wen, Yongli Zhan, Huijie Liu, Tingting Zhao, Liping Yang

BMC Complement Altern Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yi qi qing re gao attenuates podocyte injury and inhibits vascular endothelial growth factor overexpression in puromycin aminonucleoside rat model.
Yongli Zhan, Liping Yang, Yumin Wen, Huijie Liu, Haojun Zhang, Wenbing Han

Evid Based Complement Alternat Med· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of parapharyngeal-space tumors.
Keqian Zhi, Wenhao Ren, Hong Zhou, Yumin Wen, Yincheng Zhang

J Oral Maxillofac Surg· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of infant ranula.
Keqian Zhi, Yumin Wen, Wenhao Ren, Yincheng Zhang

Int J Pediatr Otorhinolaryngol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Relationship among expression of vascular endothelial growth factor-C(VEGF-C), angiogenesis, lymphangiogenesis, and lymphatic metastasis in oral cancer].
Da-hai Yu, Yu-min Wen, Jin-dong Sun, San-liang Wei, Hong-peng Xie

Ai Zheng· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis